SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-013676
Filing Date
2024-02-14
Accepted
2024-02-14 09:18:38
Documents
16
Period of Report
2024-02-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea193588-8k_citus.htm   iXBRL 8-K 27621
2 PRESS RELEASE DATED FEBRUARY 14, 2024. ea193588ex99-1_citus.htm EX-99.1 12270
6 GRAPHIC image_001.jpg GRAPHIC 4478
  Complete submission text file 0001213900-24-013676.txt   224021

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ctxr-20240214.xsd EX-101.SCH 3009
4 XBRL LABEL FILE ctxr-20240214_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ctxr-20240214_pre.xml EX-101.PRE 22355
17 EXTRACTED XBRL INSTANCE DOCUMENT ea193588-8k_citus_htm.xml XML 3608
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 24633010
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)